---All---
  • ---All---
  • Accession
  • Catalog #

Phospho-NFATC2-pS330 Antibody Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP3429a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Phospho-NFATC2-pS330 Antibody Blocking Peptide - Product info

Primary AccessionQ13469
Other AccessionNP_036472
Clone Names110162
Calculated MW100146 Da

Phospho-NFATC2-pS330 Antibody Blocking Peptide - Additional info

Gene ID 4773
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP3429a was selected from the region of human Phospho-NFATC2-pS330. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Phospho-NFATC2-pS330 Antibody Blocking Peptide - Protein Information

Name NFATC2
Synonyms NFAT1, NFATP
Function
Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF. Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway
Cellular Location
Cytoplasm. Nucleus. Note=Cytoplasmic for the phosphorylated form and nuclear after activation that is controlled by calcineurin-mediated dephosphorylation. Rapid nuclear exit of NFATC is thought to be one mechanism by which cells distinguish between sustained and transient calcium signals The subcellular localization of NFATC plays a key role in the regulation of gene transcription
Tissue Location
Expressed in thymus, spleen, heart, testis, brain, placenta, muscle and pancreas. Isoform 1 is highly expressed in the small intestine, heart, testis, prostate, thymus, placenta and thyroid. Isoform 3 is highly expressed in stomach, uterus, placenta, trachea and thyroid

Phospho-NFATC2-pS330 Antibody Blocking Peptide - Related products

AP3429a: Phospho-NFATC2-pS330 Antibody

AP3508a: Phospho-NFATC2-pS326 Antibody

AP7766a: NFATC2 Antibody (S330)

RI13570: NFATC2 predesign siRNA

BP3429a: Phospho-NFATC2-pS330 Antibody Blocking Peptide

BP3508a: Phospho-NFATC2-pS326 Antibody Blocking Peptide

BP7766a: NFATC2 Antibody (S330) Blocking Peptide

AJ1171a: CD9 Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

NFATC2 is a member of the nuclear factor of activated T cells (NFAT) family. It is a DNA-binding protein with a REL-homology region (RHR) and an NFAT-homology region (NHR). This protein is present in the cytosol and only translocates to the nucleus upon T cell receptor (TCR) stimulation, where it becomes a member of the nuclear factors of activated T cells transcription complex. This complex plays a central role in inducing gene transcription during the immune response.

REFERENCES

Golks,A., EMBO J. 26 (20), 4368-4379 (2007)Dong,X., J. Biol. Chem. 282 (41), 30303-30310 (2007)Gibson,H.M., J. Immunol. 179 (6), 3831-3840 (2007)